A detailed history of Sand Hill Global Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sand Hill Global Advisors, LLC holds 8,628 shares of LLY stock, worth $6.44 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
8,628
Previous 8,461 1.97%
Holding current value
$6.44 Million
Previous $7.66 Million 0.22%
% of portfolio
0.32%
Previous 0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $128,947 - $160,323
167 Added 1.97%
8,628 $7.64 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $6.13 Million - $7.69 Million
8,461 New
8,461 $7.66 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sand Hill Global Advisors, LLC Portfolio

Follow Sand Hill Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sand Hill Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sand Hill Global Advisors, LLC with notifications on news.